These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1089 related articles for article (PubMed ID: 18364506)
1. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506 [TBL] [Abstract][Full Text] [Related]
2. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. Bilimoria KY; Balch CM; Wayne JD; Chang DC; Palis BE; Dy SM; Lange JR J Clin Oncol; 2009 Apr; 27(11):1857-63. PubMed ID: 19273706 [TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737 [TBL] [Abstract][Full Text] [Related]
4. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
5. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
6. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer? Hieken TJ; Velasco JM Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896 [TBL] [Abstract][Full Text] [Related]
7. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
8. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
9. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150 [TBL] [Abstract][Full Text] [Related]
10. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer? Maggard MA; Lane KE; O'Connell JB; Nanyakkara DD; Ko CY Ann Surg Oncol; 2005 Jan; 12(1):41-7. PubMed ID: 15827777 [TBL] [Abstract][Full Text] [Related]
11. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection. Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912 [TBL] [Abstract][Full Text] [Related]
12. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer. Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028 [TBL] [Abstract][Full Text] [Related]
13. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL; Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245 [TBL] [Abstract][Full Text] [Related]
14. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Tan LG; Tan YY; Heng D; Chan MY Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642 [TBL] [Abstract][Full Text] [Related]
15. Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Baron RH; Fey JV; Borgen PI; Van Zee KJ Oncol Nurs Forum; 2004 Jul; 31(4):691-8. PubMed ID: 15252425 [TBL] [Abstract][Full Text] [Related]
16. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061 [TBL] [Abstract][Full Text] [Related]
17. National adoption of sentinel node biopsy for breast cancer: lessons learned from the Canadian experience. Quan ML; Hodgson N; Lovrics P; Porter G; Poirier B; Wright FC Breast J; 2008; 14(5):421-7. PubMed ID: 18657140 [TBL] [Abstract][Full Text] [Related]
18. The identification and treatment of isolated tumor cells reflect disparities in the delivery of breast cancer care. Tan JT; Bagnell M; Morgan JW; Wong JH; Roy-Chowdhury S; Lum SS Am J Surg; 2009 Oct; 198(4):508-10. PubMed ID: 19800457 [TBL] [Abstract][Full Text] [Related]
19. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832 [TBL] [Abstract][Full Text] [Related]
20. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology? Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]